Exit this survey

9th Annual C. Everett Koop Addiction Medicine Symposium:

Addressing Opioid Use Disorders: Medications That Save Lives
Expanding access to buprenorphine, methadone, depot naltrexone,
and naloxone to reduce opioid-related harm

December 3, 2015, Dartmouth-Hitchcock Medical Center, Lebanon, NH

Thank you for your participation in this year’s symposium!

We would like your feedback on your experience with the 9th annual Addiction Medicine Symposium hosted by the NEIAS and DCARE. We use your feedback in the development of future sessions, so they will meet your expectations and continuing education needs.

Your feedback is so important to us and to our accrediting bodies that we are asked to require you to complete this evaluation form before your certificate is awarded.

We thank you for training with us, and for participating in the evaluation. We will carefully consider your comments and suggestions.

Please note we ask for your name or unique identifier on the survey only to ensure confirmation of your evaluation participation and release of your certificate. Survey results will be analyzed without participant names attached.

Question Title

* 1. Please tell us about yourself:

Question Title

* 2. Profession:

Question Title

* 3. Work Setting:

Question Title

* 4. Licensures:

Question Title

* 5. Educational Degrees:

Question Title

* 6. State/Province:

Question Title

* 7. Ethnicity

Question Title

* 8. Please indicate below by which of the following method(s) you learned about this activity:

Question Title

* 9. Please complete the following statements by selecting the word(s) that describes your evaluation.

Opening remarks: Framing Current Opioid Challenges - Seddon R. Savage MD, MS - Director, Dartmouth Center on Addiction and Recovery Education, C. Everett Koop Institute at Dartmouth, Hanover, NH and Adjunct Associate Professor of Anesthesiology, Anesthesiology Psychiatry Department, Dartmouth Geisel School of Medicine, Hanover, NH

  Strongly Disagree Disagree Agree Strongly Agree N/A
This presenter's delivery was effective.
The presenter is knowledgable about the topic.

Question Title

* 10. Please complete the following statements by selecting the word(s) that describes your evaluation.

Overview of Medication Assisted Treatment for Opioid Use Disorders: Rationale, outcomes compared with psychosocial therapy alone, duration of treatments

- Sarah Akerman, MD, Assistant Professor of Psychiatry, Psychiatry Department, Dartmouth Geisel School of Medicine, Hanover, NH

  Strongly Disagree Disagree Agree Strongly Agree N/A
This presenter's delivery was effective.
The presenter is knowledgable about the topic.

Question Title

* 11. Please complete the following statements by selecting the word(s) that describes your evaluation.

Buprenorphine (Suboxone & others): Panel Exploring Models to Expand Availability

Presenters:
·         Buprenorphine: Pharmacology & Certification/Prescribing issue – John L Hammel, M.D., Assistant Professor of Psychiatry, Psychiatry Department, Dartmouth Geisel School of Medicine, Hanover, NH

·         Perspective from the VA system - John L Hammel, M.D., Assistant Professor of Psychiatry, Psychiatry Department, Dartmouth Geisel School of Medicine, Hanover, NH

·         Integration into primary care practices - Peter A. Mason, M.D., Assistant Professor of Community and Family Medicine, Department of Community and Family Medicine, Dartmouth Geisel School of Medicine, Hanover, NH

·         Free standing clinic models and integration with psychosocial groups - Heather Prebish MA, LCMHC, Clinical Director, Recover Together, Lebanon, NH

·         Buprenorphine in Methadone Maintenance Treatment clinics – Todd Mandell, M.D., Chief Medical Officer, Community Substance Abuse Services, Westfield, MA, President, Northern New England Society for Addiction Medicine

·         Special issues for pregnant women – Sarah Akerman MD, Assistant Professor of Psychiatry, Psychiatry Department, Dartmouth Geisel School of Medicine, Hanover, NH

  Strongly Disagree Disagree Agree Strongly Agree N/A
The panel presenters' delivery was effective.
The presenters on this panel are knowledgable about the topic.

Question Title

* 12. Please complete the following statements by selecting the word(s) that describes your evaluation.

Methadone maintenance: Best clinical practices: trends and models of care - Todd Mandell, M.D., Chief Medical Officer, Community Substance Abuse Services, Westfield, MA, President, Northern New England Society for Addiction Medicine

  Strongly Disagree Disagree Agree Strongly Agree N/A
This presenter's delivery was effective.
The presenter is knowledgable about the topic.

Question Title

* 13. Please complete the following statements by selecting the word(s) that describes your evaluation.

Science and clinical practice with depot naltrexone (Vivitrol)

- Tom Groblewski, DO - Statewide Medical Director, Massachusetts Partnership for Correctional Healthcare and Erik Hamel, PharmD, BCPS, Clinical Pharmacy Specialist, Centurion Managed Care

  Strongly Disagree Disagree Agree Strongly Agree N/A
This presenter's delivery was effective.
The presenter is knowledgable about the topic.

Question Title

* 14. Please complete the following statements by selecting the word(s) that describes your evaluation.

Policies for Best Practices in Pharmacologic Therapies: federal, states, third parties

- Mark Publicker, MD, Chair, Treatment Committee for Maine’s Heroin Epidemic Task Force, Portland, Maine

  Strongly Disagree Disagree Agree Strongly Agree N/A
This presenter's delivery was effective.
The presenter is knowledgable about the topic.

Question Title

* 15. Please complete the following statements by selecting the word(s) that describes your evaluation.

New Hampshire State Policies for Best Practices in Pharmacologic Therapies: 

Jack Wozmak, JD, Senior Advisor on Behavioral Health & Substance Misuse, Office of the Governor, NH

  Strongly Disagree Disagree Agree Strongly Agree N/A
This presenter's delivery was effective.
The presenter is knowledgable about the topic.

Question Title

* 16. Please complete the following statements by selecting the word(s) that describes your evaluation.

Integrating psychosocial therapies with pharmacologic treatment

- Heather Prebish MA, LCMHC, Clinical Director, Recover Together, Lebanon, NH

  Strongly Disagree Disagree Agree Strongly Agree N/A
This presenter's delivery was effective.
The presenter is knowledgable about the topic.

Question Title

* 17. Please complete the following statements by selecting the word(s) that describes your evaluation.

Pain Management in Patients on MAT for Opioid Use Disorders

– Seddon R. Savage MD, MS - Director, Dartmouth Center on Addiction and Recovery Education, C. Everett Koop Institute at Dartmouth, Hanover, NH and Adjunct Associate Professor of Anesthesiology, Anesthesiology Psychiatry Department, Dartmouth Geisel School of Medicine, Hanover, NH

  Strongly Disagree Disagree Agree Strongly Agree N/A
This presenter's delivery was effective.
The presenter is knowledgable about the topic.

Question Title

* 18. Please complete the following statements by selecting the word(s) that describes your evaluation.

Overdose Prevention with Naloxone

- Molly Rossignol, DO, Concord Hospital Family Health Center, Concord, NH

  Strongly Disagree Disagree Agree Strongly Agree N/A
This presenter's delivery was effective.
The presenter is knowledgable about the topic.

Question Title

* 19. Please complete the following statements by selecting the word(s) that describes your evaluation.

  Strongly Disagree Disagree Agree Strongly Agree N/A
As a result of attending this training, I can determine the relative strengths and limitations of specific options for medication assisted treatment of opioid addiction for individual patients and match patients to the most appropriated treatment.
As a reult of attending this training, I can integrate options for medication assisted treatment of opioid addiction into my work setting/practice systems in order to make all options available to patients.
As a reult of attending this training, I can identify and implement strategies for theprevention of opioid overdose, including naloxone distribution and patient education, in my work setting.
Overall, the specific presentation objectives were relevant to the program activity's goals/purposes.
Overall, my personal learning objectives were met.
The teaching strategies/resources were effective.
The organization, format and time frame for completing the activity was appropriate.
The content was presented without any type of bias - i.e., commercial product, drug, book, self-promotion, or any other bias. if you do not agree, please comment with details below.
Prior to the program, NEIAS staff communication (telephone, email, website registration process, etc.) was effective.
At the program, customer service from onsite NEIAS staff support was effective.
I was satisfied with this program.

Question Title

* 20. Suggested Topics for Future Addiction Medicine Symposium:

Question Title

* 21. What would you like most to see changed about this program?

Question Title

* 22. What was most helpful about this program?

Question Title

* 23. What changes, if any, do you expect in your day-to-day work as a result of having attended this program?

Question Title

* 24. Additional Comments:

Thank you for your feedback! This information will be incorporated into future planning. We appreciate you interest in the Addiction Medicine program.

T